Roche's COBAS HIV blood test cleared in Italy:
This article was originally published in Clinica
Roche Diagnostics has gained clearance to sell its COBAS AmpliScreen HIV-1 v1.5 blood test for screening HIV in Italy. The PCR-based diagnostic assay is capable of revealing very early infections that cannot be detected by currently available antibody/antigen serological assays, said the Basel, Switzerland firm. Additionally, Roche Diagnostics now has PCR-based tests approved in Australia, France, Germany and Switzerland and Italy for detecting HIV and also HCV.
You may also be interested in...
Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.